Nancy Wang, MD
Urology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Wang’s office at (408) 445-4010 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A139252 · Current
Licensed to practise in California · since 2015 · expires 2027-07-31 · University of North Carolina at Chapel Hill.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$149,658
Medicare paid this office $149,658 for 378 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Diagnostic exam of bladder and urethra using an endoscope | 107 | $29,297 | $244 |
| Return visit (30+ min) | 153 | $23,977 | $113 |
| New patient visit (45+ min) | 121 | $17,308 | $143 |
| Short return visit (20+ min) | 141 | $15,860 | $80 |
| Biopsy of prostate gland | 14 | $3,239 | $231 |
See all 13 services
| Diagnostic exam of bladder and urethra using an endoscope | 107 | $29,297 | $244 |
| Return visit (30+ min) | 153 | $23,977 | $113 |
| New patient visit (45+ min) | 121 | $17,308 | $143 |
| Short return visit (20+ min) | 141 | $15,860 | $80 |
| Biopsy of prostate gland | 14 | $3,239 | $231 |
| Simple insertion of temporary bladder tube | 21 | $2,765 | $61 |
| Ultrasound measurement of bladder capacity after voiding | 159 | $2,556 | $12 |
| Ultrasound scan of pelvic region through rectum | 16 | $2,535 | $149 |
| Long return visit (40+ min) | 12 | $2,249 | $173 |
| Short return visit | 38 | $2,215 | $50 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | 11 | $1,957 | $163 |
| New patient visit (30+ min) | 12 | $985 | $82 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 18 | $284 | $15 |
Procedures Medicare counted
| Prostate resection | 1-10 | None |
Who their Medicare patients are
378 Original Medicare patients in 2024. Average age 76 · Under 65 5% · 85 and older 14% · Women 48% · Also on Medicaid 12% · Health risk score 1.03. At or below the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 67% · Diabetes 24% · Chronic kidney disease 24% · Cancer 24% · Coronary heart disease 23% · Depression 18% · Atrial fibrillation 17% · Heart failure 10% · COPD 9% · Dementia 8% · Stroke 8%.
The office billed $656,852, Medicare allowed $198,464 and paid $149,658; for 11,027 services of 64 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 378 | 11,027 | 76 | 1.03 | $656,852 | $149,658 |
| 2023 | 393 | 9,414 | 75 | 1.04 | $609,490 | $145,998 |
| 2022 | 299 | 1,743 | 76 | 0.95 | $438,750 | $100,959 |
| 2021 | 315 | 926 | 75 | 0.93 | $480,803 | $113,072 |
| 2020 | 109 | 240 | 75 | 1.05 | $128,905 | $29,487 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Diagnostic exam of bladder and urethra using an endoscope | 110 | $33,258 | $252 |
| New patient visit (45+ min) | 152 | $22,427 | $148 |
| Return visit (30+ min) | 116 | $15,039 | $113 |
| Short return visit (20+ min) | 109 | $13,796 | $81 |
| Biopsy of prostate gland | 14 | $3,345 | $239 |
| Long return visit (40+ min) | 15 | $3,309 | $174 |
| New patient visit (30+ min) | 37 | $3,221 | $87 |
| Short return visit | 52 | $3,126 | $50 |
| Ultrasound measurement of bladder capacity after voiding | 165 | $2,487 | $11 |
| Ultrasound scan of pelvic region through rectum | 14 | $2,407 | $150 |
| Simple insertion of temporary bladder tube | 18 | $2,397 | $63 |
| Insertion of temporary bladder tube | 12 | $518 | $40 |
2022: 12 services
| Diagnostic exam of bladder and urethra using an endoscope | 85 | $24,441 | $255 |
| New patient visit (45+ min) | 88 | $12,754 | $145 |
| Short return visit (20+ min) | 72 | $6,889 | $82 |
| Return visit (30+ min) | 57 | $6,647 | $111 |
| New patient visit (30+ min) | 48 | $4,865 | $101 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 14 | $4,652 | $332 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 11 | $4,430 | $369 |
| Short return visit | 42 | $2,702 | $48 |
| Long return visit (40+ min) | 13 | $2,595 | $173 |
| Ultrasound measurement of bladder capacity after voiding | 112 | $1,526 | $11 |
| Simple insertion of temporary bladder tube | 13 | $1,480 | $64 |
| Telephone medical discussion with physician, 5-10 minutes | 18 | $1,021 | $39 |
2021: 10 services
| Diagnostic exam of bladder and urethra using an endoscope | 83 | $23,153 | $246 |
| New patient visit (45+ min) | 125 | $19,132 | $153 |
| Short return visit (20+ min) | 88 | $10,815 | $86 |
| Return visit (30+ min) | 64 | $8,201 | $122 |
| New patient visit (30+ min) | 42 | $4,289 | $102 |
| Long return visit (40+ min) | 19 | $3,841 | $175 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | 11 | $2,656 | $221 |
| Short return visit | 35 | $2,183 | $55 |
| Ultrasound measurement of bladder capacity after voiding | 136 | $2,031 | $11 |
| Insertion of stent in ureter using an endoscope | 12 | $1,991 | $142 |
2020: 5 services
| New patient visit (45+ min) | 61 | $9,485 | $155 |
| Diagnostic exam of bladder and urethra using an endoscope | 20 | $4,607 | $219 |
| Return visit (30+ min) | 16 | $1,626 | $102 |
| Short return visit (20+ min) | 13 | $1,061 | $71 |
| Ultrasound measurement of bladder capacity after voiding | 44 | $537 | $11 |
Drugs they prescribed that Part D paid
$91,585
Pharmacies billed $91,585 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (14 of 1,040) in 2024. At or below the middle of the specialty; the typical urology clinician is at 2%.
925 generic and fewer than 11 brand-name prescriptions · $91,585 in drug cost · 273 antibiotic prescriptions to 105 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 74 | $41,433 | $560 |
| Gemtesa | 33 | $23,014 | $697 |
| Trospium Chloride Er | 25 | $5,768 | $231 |
| Tamsulosin | 257 | $5,640 | $22 |
| Trospium Chloride | 121 | $4,370 | $36 |
See all 18 drugs
| Myrbetriq | 74 | $41,433 | $560 |
| Gemtesa | 33 | $23,014 | $697 |
| Trospium Chloride Er | 25 | $5,768 | $231 |
| Tamsulosin | 257 | $5,640 | $22 |
| Trospium Chloride | 121 | $4,370 | $36 |
| Finasteride | 100 | $2,132 | $21 |
| Estradiol | 24 | $1,050 | $44 |
| Solifenacin | 19 | $877 | $46 |
| Cephalexin | 116 | $739 | $6 |
| Methenamine Hippurate | 12 | $551 | $46 |
| Cefdinir | 25 | $317 | $13 |
| Nitrofurantoin Mono-Macro | 14 | $299 | $21 |
| Oxybutynin Chloride Er | 11 | $236 | $21 |
| Sulfamethoxazole-Trimethoprim | 44 | $197 | $4 |
| Levofloxacin | 22 | $129 | $6 |
| Ciprofloxacin | 42 | $124 | $3 |
| Terazosin | 14 | $98 | $7 |
| Oxycodone | 13 | $88 | $7 |
Year by year
| 2024 | 1,040 | 267 | 1% (14) | None | $91,585 |
| 2023 | 757 | 221 | None | None | $79,672 |
| 2022 | 474 | 151 | None | None | $32,714 |
| 2021 | 387 | 140 | None | None | $25,639 |
| 2020 | 98 | 55 | None | None | $4,923 |
| 2019 | 70 | 49 | 54% (38) | None | $682 |
| 2018 | 26 | 26 | 100% (26) | 0% | $130 |
| 2017 | 18 | 14 | 78% (14) | 0% | $122 |
| 2016 | 45 | 36 | 73% (33) | None | $925 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Myrbetriq | 59 | $38,215 | $648 |
| Gemtesa | 23 | $17,605 | $765 |
| Tamsulosin | 209 | $6,027 | $29 |
| Trospium Chloride | 66 | $3,371 | $51 |
| Solifenacin | 21 | $2,029 | $97 |
| Finasteride | 72 | $1,229 | $17 |
| Estradiol | 13 | $851 | $65 |
| Cephalexin | 86 | $591 | $7 |
| Cefdinir | 20 | $541 | $27 |
| Sulfamethoxazole-Trimethoprim | 44 | $377 | $9 |
| Ciprofloxacin | 27 | $153 | $6 |
2022: 10 drugs
| Myrbetriq | 12 | $11,113 | $926 |
| Solifenacin | 28 | $4,354 | $155 |
| Tamsulosin | 138 | $3,857 | $28 |
| Estradiol | 22 | $2,237 | $102 |
| Finasteride | 67 | $1,229 | $18 |
| Cephalexin | 41 | $318 | $8 |
| Nitrofurantoin Mono-Macro | 14 | $216 | $15 |
| Cefdinir | 12 | $214 | $18 |
| Sulfamethoxazole-Trimethoprim | 33 | $209 | $6 |
| Levofloxacin | 12 | $36 | $3 |
2021: 6 drugs
| Solifenacin | 40 | $6,652 | $166 |
| Tamsulosin | 120 | $1,988 | $17 |
| Finasteride | 36 | $628 | $17 |
| Cephalexin | 48 | $263 | $5 |
| Ciprofloxacin | 23 | $83 | $4 |
| Levofloxacin | 12 | $45 | $4 |
2020: 2 drugs
| Tamsulosin | 33 | $415 | $13 |
| Finasteride | 15 | $235 | $16 |
2019: 2 drugs
| Hydrocodone-Acetaminophen | 13 | $84 | $6 |
| Tramadol | 14 | $47 | $3 |
2018: 1 drug
| Tramadol | 13 | $61 | $5 |
2016: 1 drug
| Hydrocodone-Acetaminophen | 24 | $336 | $14 |
Professional record
- NPI
- 1891105706
- Licence
- CA A139252California A139252: Current · expires 2027-07-31
- Trained
- University of North Carolina at Chapel Hill School of Medicine, 2014
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2014-04-30
- NPI last updated
- 2020-08-24
- NPI record certified
- 2020-08-24
This is when the NPI record was last certified, not a medical board exam.